Partnering

BerGenBio retains full global development, marketing and commercialisation rights for its product candidates. As we further advance BGB324 and other drug candidates in our pipeline, we will seek partners to maximise clinical and commercial opportunities worldwide.

Please direct Corporate Development inquiries to:

Richard.Godfrey, CEO, BerGenBio AS

partnering@bergenbio.com